SPARC and gastric cancer: Further more, a meta-analysis[11] indicated the negative prognostic value of SPARC expression in patients with gastric cancer, with the relative risk of OS (RR = 1.78, 95% CI: 1.52–2.09, Z = 7.10, p = 0.43).